KRYS

KRYS 13F Holders & Ownership Data (369 Funds)

Krystal Biotech INC

+$340.9M

Net Activity

Institutions Holding

369

Popularity Rank

#1586

Avg Weight

0.26%

Total Value

$7.4B

Ownership Trend

369 institutions currently hold KRYS, with 208 net buyers and 141 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

141

Net Buying Institutions

208

Key Holders

Key Holders

Top 5 by Value

BlackRock, Inc.

Avoro Capital Advisors LLC

Vanguard Portfolio Management LLC

State Street CORP

Top 5 by Conviction

Act Capital Management, LLC

Soleus Capital Management, L.P.

Redmile Group, LLC

S Squared Technology, LLC

Avoro Capital Advisors LLC

View all 369 holding institutions

Quarterly Activity

Recent Activity

+$4.3B

Total Buy Value

$2.0B

Total Sell Value

New buy67

Trim105

Add141

Sold out36

208

Net Buyers

141

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

3

Filings (90d)

$15.44M

Total Est. Value

51K shares

Planned Shares

Last Filed 2026-06-25

Filer	Title/Relationship	Filing Date	Planned Shares	Est. Value
Thomas John Charles	Officer	2026-06-25	1K shares	$347K
Krishnan Suma	Director, Officer, 10% Stockholder	2026-06-04	25K shares	$7.55M
Krishnan Krish S	Director, Officer, 10% Stockholder	2026-06-04	25K shares	$7.55M

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding KRYSTAL BIOTECH INC (KRYS)?

Major stakeholders currently include FMR LLC ($1.1B), BlackRock, Inc. ($1.0B), Avoro Capital Advisors LLC ($746.3M). Based on the latest 13F filings, there are a total of 369 tracked investment funds and institutions maintaining positions in KRYS.

What is the overall institutional sentiment toward KRYS recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $340.9M, driven by 208 managers accumulating shares while 141 reduced their exposure.

Which institutions have been selling or reducing their KRYS positions?

In the latest period, 105 funds trimmed their holdings, and 36 managers completely exited their positions. The aggregate reported sell value was $2.0B.

Are there any notable investors adding KRYS to their portfolios?

Yes, buying activity remains notable. 67 institutions opened new positions in {ticker}, and 141 existing holders added to their shares. The total reported buy value for the quarter amounted to $4.3B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

Johnson & Johnson

Institutions Holding

4,603

Total reported value

$438.8B

318 institutions currently hold both KRYS and this stock

Eli Lilly & Co

Institutions Holding

4,337

Total reported value

$730.5B

329 institutions currently hold both KRYS and this stock

Abbvie INC

Institutions Holding

4,024

Total reported value

$283.9B

313 institutions currently hold both KRYS and this stock

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

Microsoft CORP

Institutions Holding

6,150

Total reported value

$2.1T

3245 13F institutions increased their position this quarter

Amazon.com INC

Institutions Holding

5,957

Total reported value

$1.5T

3028 13F institutions increased their position this quarter

Nvidia CORP

Institutions Holding

5,764

Total reported value

$3.0T

2743 13F institutions increased their position this quarter